Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roban Shabbir has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Low-grade osteogenic tumor with secondary aneurysmal bone cyst: Distinguishing osteoblastoma from low-grade osteosarcoma in the setting of noncanonical molecular findings

    by Roban Shabbir-Hussain, Romina Malerba, Reem Aljohani, Julius Nani, Muhammad Hussain, Daniela Proca

  • Failure Modes of Total Wrist Arthroplasty: Cross-Sectional Analysis of FDA MAUDE Adverse Event Reports (2015-2025)

    by Roban Shabbir, Brendan Layton, Zion Kang, Paulo Parente, David Riopelle, Luke Nicholson, Ali Azad

    Background: Total wrist arthroplasty (TWA) is a motion-preserving alternative to wrist fusion for end-stage wrist arthritis, but concerns regarding long-term durability continue to limit broader use. Reported 10-year survivorship ranges from 70% to 80%, although real-world failure patterns remain poorly defined. Methods: Adverse events were reviewed for TWA devices submitted to the U.S. Food and Drug Administration Manufacturer and User Facility Device Experience database from January 1, 2015, to September 30, 2025. Reports were identified using the wrist arthroplasty device code and confirmed by manufacturer and implant name. Nonwrist devices and duplicate submissions were excluded. Event narratives were manually reviewed and assigned a primary failure mode using a predefined taxonomy. Reports lacking sufficient detail were excluded from analyses. Results: Among 313 unique reports with adequate information, loosening or component migration was the most common failure mode (37%), followed by dislocation or instability (18%) and infection (13%). Less common complications included tendon or nerve injury, polyethylene wear or metallosis, implant fracture, and periprosthetic fracture. Annual failure-mode reports peaked in 2022, with additional clustering in 2018 and 2019. Loosening/migration was most frequent in 2022, whereas dislocation/instability clustered in 2019. Manufacturer-year reporting was mostly by Stryker and Zimmer Biomet, though reports involved all manufacturer groups. Conclusions: These findings describe submitted adverse events rather than true failure rates and reflect the limitations of passive reporting. Contemporary TWA continues to encounter substantial mechanical and fixation-related complications, highlighting the need for improved implant design, refined technique, and stronger post-market surveillance.

  • Open Access

    Evaluating Factors Influencing Patient Reviews: Variations in Professional Credentials and Demographics of Orthopedic Oncologists

    by Roban Shabbir, Annika Surapaneni, Orrin Wilson, Robert Hoy, Saqib Rehman

    Background: Orthopedic oncology depends on strong patient-provider relationships and advanced expertise. Patients in this specialized and nuanced field rely on online platforms, such as U.S. News & World Report (USNWR), to guide their decision-making. While these platforms provide insights into patient satisfaction, they may fail to capture critical nuances such as academic background, research focus, and training recency. This study aims to evaluate the influence of U.S. News physician ratings on patient perceptions of orthopedic oncologists and their correlation with professional credentials. Methods: This retrospective analysis identified 312 fellowship-trained active American orthopedic oncologists through ACGME-accredited orthopedic surgery residency programs and the Musculoskeletal Tumor Society. Ratings of 228 physicians were obtained from USNWR using Press Ganey analytics and normalized with calculated Bayesian (weighted) averages. Statistical analyses used Mann-Whitney U tests for two-group comparisons and Kruskal-Wallis tests for comparisons with >2 groups. When Kruskal-Wallis tests were significant, post-hoc pairwise Mann-Whitney U tests with Holm adjustment were performed. Results: Non-academic physicians received significantly higher overall patient satisfaction scores than their academically appointed counterparts. Notably, physicians with PhDs had significantly lower ratings in categories such as follow-up care, time spent with patients, attitude, inclusion in decision-making, and overall feedback. Recent residency graduates (2011-2020) demonstrated significantly higher ratings in clarity of instructions, provider follow-up, and provider attitude compared to earlier cohorts (P<0.05). Conclusion: Patients appear to prioritize factors including accessibility and communication, favoring non-academic physicians and recently trained providers. Lower patient experience scores observed among PhD-trained physicians may reflect differences in practice structure, patient expectations, or unmeasured confounding, although this warrants further study. Limitations include incomplete and variable review data. Though U.S. News ratings provide valuable insights, they may not fully reflect the multifaceted nature of quality care in orthopedic oncology. A more comprehensive model, incorporating clinical outcomes, peer assessments, and patient-reported experiences, is essential to understanding and improving patient satisfaction with clinician practice and characteristics.

  • Unstable distal clavicle fractures: Outcomes of internal fixation of clavicle and coracoclavicular stabilization

    by Jacquelyn J Xu, Brian O Molokwu, Roban Shabbir-Hussain, C Lucas Myerson, Young W Kwon, Mandeep S Virk

    Background: This study evaluates outcomes following internal fixation of unstable distal clavicle fractures (DCFs) with or without coracoclavicular (CC) stabilization. Methods: A retrospective review was conducted for patients who underwent open repair of unstable DCFs at a single institution from 2017 to 2024. Fixation techniques included locking plate alone (P) or plate with CC stabilization [transcoracoid suture button (P + B), coracoid anchor (P + A)]. Collected variables included demographics, clinical details, patient-reported outcome measurement information system (PROMIS) scores, American Shoulder and Elbow Surgeons (ASES) scores, and Visual Analog Scale (VAS) Pain. Results: Seventeen patients with DCFs (17 shoulders;11 males, 6 females; mean age 45 [23–78] years) were followed for an average of 32.0 (3.4–69.3) months. Fixation groups included P (6), P + B (8), and P + A (3). Neer types included IIA (4), IIB (6), and V (7). Mean outcome scores were PROMIS upper extremity 49.2 ± 10.5, pain interference 47.0 ± 7.2, pain intensity 39.3 ± 7.0, ASES 89.3 ± 14.3, and VAS 1.5 ± 2.2. Three patients (18%) experienced postoperative issues: plate prominence (2) and shoulder stiffness (1); none required reoperation. Discussion: The addition of CC stabilization to locking plate fixation in high-risk unstable DCFs results in favorable outcomes and predictable healing rates. Level of evidence: IV, case series.

  • Open Access

    Exploring Disparities in Post-Fracture Osteoporosis Pharmacotherapy Initiation: A Retrospective Cohort Study Utilizing the All of Us Research Database

    by Roban Shabbir, Shums Lareef, Zion Kang, Brendan Layton, Robert Hoy, Saqib Rehman

    Background/Objectives: Osteoporosis-related fragility fractures are sentinel events that should trigger timely secondary prevention, yet post-fracture care remains inconsistent. Leveraging the NIH All of Us Research Program, we quantified initiation of osteoporosis pharmacotherapy after fragility fracture and explored associations by age, sex at birth, race, and ethnicity. Methods: Retrospective cohort study using All of Us Controlled Tier data (v8) included adults aged 45 to 100 years with an index fragility fracture using prespecified OMOP concept sets intended to capture fractures commonly associated with osteoporosis. A new-user design excluded participants with any osteoporosis pharmacotherapy in the 365 days before fracture; participants required at least 180 days of follow-up. The primary outcome was initiation of osteoporosis pharmacotherapy (bisphosphonates, denosumab, or anabolic agents) within 180 days. Secondary outcomes were completion of dual-energy x-ray absorptiometry (DXA) and bone-health laboratory testing within 180 days. Multivariable logistic regression estimated adjusted odds ratios (OR) for each outcome by age at fracture, sex at birth, race, and ethnicity. Results: Among 1492 eligible participants, 87 initiated pharmacotherapy within 180 days (5.83%). After adjustment, older age was associated with higher odds of initiation (OR 1.04 per year; 95% CI 1.02 to 1.05). Male participants had markedly lower odds of pharmacotherapy initiation (OR 0.20; 95% CI 0.11 to 0.37) and DXA screening (OR 0.22; 95% CI 0.15 to 0.32) compared with female participants. In exploratory adjusted models, we did not detect an independent association between race and pharmacotherapy initiation (White vs. Black/African American OR 1.01; 95% CI 0.49 to 2.09), while White participants had higher odds of DXA screening than Black/African American participants (OR 1.79; 95% CI 1.02 to 3.28). Conclusions: In this diverse national EHR-based cohort, initiation of osteoporosis pharmacotherapy after fracture was uncommon, highlighting a substantial secondary prevention gap. In exploratory adjusted models, male sex was associated with lower odds of pharmacotherapy initiation and DXA receipt, while White participants had higher odds of DXA receipt than Black participants. System-level post-fracture pathways, including fracture liaison services and EHR-based prompts, may improve equitable identification and treatment of osteoporosis for All of Us participants and their communities.


  • Regional trends in total ankle arthroplasty: A medicare analysis of volume, reimbursement, and patient demographics from 2013 to 2022

    by Megan Hsu, Ryan D. Stadler, Anisha Tyagi, Suleiman Y. Sudah, Joseph E. Manzi, Roban Shabbir, Sydney Thai, Glenn Gabisan


  • Open Access

    Preoperative risk factors associated with patient outcomes following arthroscopic elbow contracture release

    by Jacquelyn J. Xu, Brian O. Molokwu, Bradley A. Lezak, Roban Shabbir-Hussain, Tanzeel Sultan, C. Lucas Myerson, Mandeep S. Virk, Young W. Kwon

  • Open Access

    Recent developments in pediatric interventional radiology: growth, innovation, and clinical outcomes

    by Roban Shabbir, Rushil Reddy, Leonel Camejo, Nagendra Dhanikonda, Ashley Woodford, Jared Meshekow

    Background: Over the past two decades, Pediatric Interventional Radiology (PIR) has matured from the adaptation of adult techniques into a distinct subspecialty that provides minimally invasive, image-guided interventions specifically tailored to this vulnerable population. These procedures accommodate several unique anatomical considerations, physiological responses, and disease presentations seen in pediatrics from infants to adolescents. Methods: A literature review was conducted to identify articles published from January 1, 2010, to June 1, 2025, that included the terms “pediatric” and “interventional radiology” in their titles or abstracts. Twenty five studies were selected and synthesized, along with relevant historical data, regarding workforce development and device progression. Results: The availability of PIR services in children’s hospitals increased by over 130%, alongside a threefold increase in fellowship-trained pediatric interventional radiologists and a fourfold increase in membership within the Society for Pediatric Interventional Radiology. During this time, specialized pediatric devices, such as specific catheters, micro-wires, and stents, are now used to appropriately treat approximately 25% of common procedural needs, thereby limiting the need for the improvised use of adult equipment. Technical procedural completion rates consistently exceed 90% for central venous catheter placements, gastrostomy insertions, abscess drainages, vascular malformation sclerotherapy, intussusception reductions, and trauma-related embolizations. Comparative studies even demonstrate that PIR’s minimally invasive nature results in shorter hospital stays and lower complication rates than equivalent surgical treatments. Advancements in radiation-sparing techniques, including adherence to the ALARA principles, routine ultrasound-first imaging, and tailored sedation protocols, have collectively reduced radiation exposure by half while maintaining major complication rates below 2%. Furthermore, family satisfaction rates remain high, indicating that both parents and physicians recognize the advantages of minimal scarring, rapid recovery, and comprehensive child-life support. Even so, significant gaps persist, such as limited pediatric device availability, variability in radiation safety metrics, and a scarcity of longitudinal outcomes data. Conclusions: PIR now plays a critical role in pediatric healthcare and infrastructure, providing precise yet efficient, low-morbidity alternatives to traditional surgical interventions for congenital, malignant, and traumatic conditions. The field will continue to progress, and may require focused device innovation, standardized radiation safety practices, and multicenter longitudinal registries to further enhance patient outcomes and family-centered care.

  • Open Access

    Characteristics and outcomes of cubital tunnel decompression in diabetic patients receiving glucagon-like peptide-1 receptor agonists

    by Roban Shabbir, Simran Shamith, Paulo E. L. Parente, Luke Nicholson, Azad Ali

    Background: Cubital tunnel release (CuTR) relieves ulnar nerve compression; however, about 35% of patients who undergo this procedure develop persistent neuropathy and about 7% require revision. Type 2 diabetes mellitus (T2DM) worsens ulnar neuropathy, whereas glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be neuroprotective. We compared short- (90-day) and mid-term (2-year) CuTR outcomes in diabetic patients who did or did not receive perioperative GLP-1 RA treatment.Methods: TriNetX identified adults (≥18 years) with T2DM who underwent primary CuTR during the period 2015–2023, and who underwent at least 2 years of follow-up. The experimental cohort had received an active GLP-1 RA prescription at surgery, while the controls had not. Exclusion criteria were T1DM, pancreatitis, multiple endocrine neoplasia 2, systemic steroids, end-stage renal disease, or prior major CuTR. Propensity-score matching (1:1) balanced demographics, body mass index, glycated hemoglobin (HbA1c), creatinine, and comorbidities. Outcomes were captured using International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) and Current Procedural Terminology (CPT) codes.Results: After matching, 1,766 pairs of patients (mean age, 58 years; 46% female) were analyzed. At 90 days, fewer GLP-1 RA users had emergency-department visits than non-users (8.9% vs. 10.7%, P=0.048). Despite higher HbA1c at each timepoint, GLP-1 RA users showed a larger decline. At 2 years, GLP-1 RA exposure was associated with fewer reoperations (5.2% vs. 6.9%, P=0.028), less frequent neuropathy (23.4% vs. 30.4%, P<0.001), and fewer inpatient admissions (14.6% vs. 17.2%, P=0.030). Major medical complications did not differ in occurrence between the groups.Conclusions: Perioperative GLP-1 RA therapy in diabetic patients undergoing CuTR correlated with fewer 90-day emergency visits and lower 2-year risks of revisional surgery and ICD-coded ulnar neuropathy (all-cause, non-adjudicated).. These findings support a potential protective role of GLP-1 RAs in this surgical population. Evidence: III.